Recce Ltd has released a press release.
RCE Awarded AusIndustry Advanced Overseas Anti-Viral Finding
Filed with ASX ·
6ix hasn’t read this filing yet.
Recce Pharmaceuticals Ltd. on 6ix
Earlier from Recce Pharmaceuticals
- Recce Awarded AusIndustry Advanced Overseas (R&D) Finding
- Anti-Viral Patent Granted in Japan for RECCE Anti-Infectives
- Encouraging Results Against SARS-CoV-2 Virus
- HREC Approval to Start Phase I/II Burns Wound Study
- Murdoch Childrens Research Institute, R435 Against H.Pylori
Later from Recce Pharmaceuticals
- Positive Intranasal Animal Data against SARS-CoV-2 in Study
- R&D Incentive Rebate Received
- Further Encouraging COVID Results at Doherty
- Fiona Stanley Hospital Phase I/II Clinical Trial Agreement
- Recce Applies for Dual Listing on Frankfurt Stock Exchange
Follow Recce Pharmaceuticals into a list and get an email when it puts out news.
Follow Recce Pharmaceuticals